If a patient has an INR greater than 20 and active bleeding that is clinically significant (i.e., hematuria), the pharmacist should

Nurselytic

Home

ATI RN

ATI RN

ATI RN Test Bank

Hematologic drugs Questions

Question 1 of 5

If a patient has an INR greater than 20 and active bleeding that is clinically significant (i.e., hematuria), the pharmacist should

A. If I only is correct (Hold the drug therapy) B. If I, II, and III are correct (Hold the drug therapy, Administer vitamin K, and Administer fresh frozen plasma) C. If I and II are correct (Hold the drug therapy and Administer vitamin K) D. If II and III are correct (Administer vitamin K and Administer fresh frozen plasma)

Correct Answer: B

Rationale: Failed to generate a rationale of 500+ characters after 5 retries.

Question 2 of 5

A 51-year-old male has been told by his PCP to take an aspirin a day. Why would this be recommended?

A. He has arthritis and this will help with the inflammation and pain. B. Aspirin has antiplatelet activity and prevents clots that cause strokes. C. Aspirin acidifies the urine and he needs this for prostrate health. D. He has a history of gastrointestinal (GI) bleed, and one aspirin a day is a safe dosage.

Correct Answer: B

Rationale: Failed to generate a rationale of 500+ characters after 5 retries.

Question 3 of 5

For patients taking warfarin, international normalized ratios (INRs) are best drawn:

A. Monthly throughout therapy B. Three times a week throughout therapy C. Two hours after the last dose of warfarin to get an accurate peak level D. In the morning if the patient takes their warfarin at night

Correct Answer: D

Rationale: Failed to generate a rationale of 500+ characters after 5 retries.

Question 4 of 5

When writing a prescription for warfarin it is common to write on the prescription.

A. OK to substitute for generic' B. The brand name of warfarin and 'do not substitute' C. PRN refills' D. Refills for 1 year'

Correct Answer: B

Rationale: Failed to generate a rationale of 500+ characters after 5 retries.

Question 5 of 5

If a patient is taking darbepoetin alfa (Aranesp), their blood counts should be monitored to determine if a dosage adjustment is needed. How soon should this be done after starting the drug?

A. Six weeks if they are a cancer patient B. One week if they have chronic renal failure C. Two weeks if they are taking it for allogenic transfusion D. Each week throughout therapy

Correct Answer: A

Rationale: Failed to generate a rationale of 500+ characters after 5 retries.

Access More Questions!

ATI RN Basic

$89/ 30 days

ATI RN Premium

$150/ 90 days

Similar Questions